The Israel Ministry of Health and the Israel Innovation Authority, along with Sourasky (Ichilov) Medical Center and Rambam Health Care Campus in addition to a startup venture called Geneyx have formed a public-private consortium that will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the aim of identifying new diagnostic and treatment methods. The startup offers next-generation sequencing data analysis, interpretation, reporting and storage products and services.
Led by Israeli Innovation Authority Funding
The Israeli Innovation Authority has invested about $838,500 for the project; another participant—BATM, a private firm in Israel is also offering to contribute funding but wouldn’t specific the amount. The total project budget is expected to exceed $1.5 million. The Israel Innovation Authority previously known as the Office of the Chief Scientist of Israel's Ministry of Economy is the support arm of the Israeli government, charged with fostering the development of industrial R&D within the State of Israel.
Patient Data Collection
Of course, the collection of COVID...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).